US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

(OP:FUNI)

0.0044 -0.0001 (-2.22%)
Delayed Quote Updated: 3:53 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about FUNI

News headline image
Hypha Labs Targets Disruptive Mushroom Active Ingredient Production
Eight-Day Cycles and Potential 80% Cost Savings 
From Hypha Labs, Inc.
Via ACCESS Newswire
News headline image
The Functional Mushroom Revolution Has Begun
From Hypha Labs, Inc.
Via ACCESS Newswire
News headline image
Hypha Labs (OTCQB:FUNI) Sees State-by-State Psilocybin Reform Creating the Next Major Growth Opportunity
From Hypha Labs, Inc.
Via ACCESS Newswire
News headline image
Hypha Labs Highlights Parallels Between Emerging Psychedelic Industry and Early Cannabis Market Expansion
Via ACCESS Newswire
News headline image
Trump Psychedelic Executive Order Accelerates Industry Growth
Via ACCESS Newswire
News headline image
Hypha Labs, Inc. (OTCQB:FUNI) Announces Partnership with Mycology Resources, LLC
Via ACCESS Newswire
News headline image
Hypha Laboratories Reports Significant Breakthrough for MicroPearls(TM) Yields
Via ACCESS Newswire
News headline image
Hypha Laboratories Applauds Call for Regulatory Changes for Functional Mushrooms
Via ACCESS Newswire
News headline image
Hypha Laboratories Announces Completion of Phase 1 of Its State-of-the-Art Facility and Arrival of V5 Working MicroPearls(TM) Prototypes
Via ACCESSWIRE
News headline image
Hypha Labs and Tryptomics Launch Phase II of Strategic Partnership, Pairing Patented Mushroom Accelerator(TM) with World-Class Internal Quality Control & Fungal Genomics
Via ACCESS Newswire
News headline image
Hypha Labs and Automated Technical Services (ATS) Enter into Agreement to Scale its Mushroom Accelerator Technology for Commercial Nutraceutical Manufacturing
Via ACCESS Newswire
News headline image
Hypha Labs’ Countertop Cultivation Device Is A Game-Changer For Functional Foods And Wellness (OTCQB: FUNI)
Via AB Newswire
News headline image
Hypha Labs Expands List of Functional Mushrooms Able to be Produced in its Revolutionary Mushroom Accelerator
Via ACCESS Newswire
News headline image
Hypha Laboratories Establishes Scientific and Cultural Advisory Board, Adds William Padilla-Brown
Via ACCESSWIRE
News headline image
Hypha Laboratories Reveals New Patent Applications for Novel A.I. Driven In-Home Mycelium Production
Via ACCESSWIRE
News headline image
Hypha Labs, Inc. Reveals First Functional Mushroom Ingredient Array for Home and Commercial Production
Via ACCESSWIRE
News headline image
Hypha Labs Provides Shareholder Update
Via ACCESS Newswire
News headline image
Hypha Labs Files New Patent Application for Its Suite of Artificial Intelligence (AI) Techniques for Its Mushroom Accelerator
Via ACCESS Newswire
News headline image
Hypha Labs Files Multiple Additional Patents for its Ground Breaking Mushroom Accelerator
Via ACCESS Newswire
News headline image
Hypha Labs Acquires State-of-the-Art HPLC Analytic Machine and Partners with Lucidity Systems for Advanced Autosampler Upgrade
Via ACCESS Newswire
News headline image
Hypha Labs, Inc. Releases Investor Presentation
Via ACCESSWIRE
News headline image
Hypha Labs, Inc. Uplists to the OTCQB
Via ACCESSWIRE
News headline image
New Mexico Governor Signs Bill Allowing for Psilocybin Use
Via ACCESS Newswire
News headline image
Hypha Laboratories Retains Stockhouse for International Awareness Campaign
Via ACCESS Newswire
News headline image
Functional Mushroom Company Hypha Labs Retains Emerging Markets Consulting LLC for Investor Relations Advisory Services
Via ACCESSWIRE
News headline image
Hypha Labs' Revolutionary Psilocybin Bioreactor Nominated for Best New Product of 2024 by Santa Monica Daily Press
Via ACCESSWIRE